Position and Esophageal Pressure (pEsition)

September 5, 2025 updated by: Hospices Civils de Lyon

Impact of Patient Position on the Value of Esophageal Pressure. pEsition Study.

Esophageal pressure measurements are used in moderate/severe Accurate Respiratory Distress SyndromeARDS patients in order to set ventilator settings. There might be variations of the measured value according to the patient position (0° vs 30°) at the time of measurements.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

11

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lyon, France, 69004
        • Hôpital Croix-Rousse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥ 18 years
  • Acute respiratory failure defined by PaO2/FIO2< 300 mmHg or pH<7,35 and pCO2>45mmHg or Moderate or severe Accurate Respiratory Distress Syndrome ARDS defined by:

    • New or worsening respiratory symptoms in the previous week.
    • Bilateral opacities-not fully explained by effusions, lobar/lung collapse, or Nodules
    • Respiratory failure not fully explained by cardiac failure or fluid overload
    • PaO2/FIO2< 200 mmHg and PEEP ≥ 5 cm H2O and VT ≤6 ml/kg of Ideal Body Weight
  • Patient intubated or tracheotomized and receiving mechanical ventilation
  • Indication of esophageal measurement decided by the clinician

Exclusion Criteria:

  • Contraindication to naso-gastric tube insertion :

    • Recent gastro-duodenal ulcer
    • Stage III esophageal varices
  • Refractory intracranial hypertension
  • Unstabilized spine fracture
  • Surgical contraindication
  • Burns on more than 20 % of the body surface
  • Underlying disease with a life expectancy of less than one year
  • End-of-life decision before inclusion
  • Pregnant or breast-feeding patients
  • Subject deprived of freedom, minor, subject under a legal protective measure
  • Research team unavailability
  • Lack of medical care plan

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: head-bed position
Head-bed position at 0° for 30 minutes then head-bed position at 30° for 30 minutes
Head-bed position at 0° for 30 minutes then head-bed position at 30° for 30 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total End-expiratory esophageal pressure
Time Frame: 30min after change of position
After end-expiratory pause on the ventilator, absolute value of the esophageal pressure is measured (in Head-bed position at 30° then in head-bed position at 0° )
30min after change of position

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
End-inspiratory esophageal pressure
Time Frame: 30min after change of position
After end-inspiratory pause on the ventilator, absolute value of the esophageal pressure is measured (in Head-bed position at 30° then in head-bed position at 0° )
30min after change of position
Gastric pressure
Time Frame: 30min after change of position
After end-expiratory pause and end-inspiratory pause on the ventilator, absolute value of the gastric pressure is measured (in Head-bed position at 30° then in head-bed position at 0° )
30min after change of position
End-expiratory lung volume
Time Frame: 30min after change of position
End-expiratory lung volume is measured with nitrogen wash-in wash-out method, available in the ventilator (in Head-bed position at 30° then in head-bed position at 0° )
30min after change of position

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Claude Guerin, Pr, Hospices civils de Lyon

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2016

Primary Completion (Actual)

September 1, 2017

Study Completion (Actual)

September 1, 2017

Study Registration Dates

First Submitted

June 24, 2016

First Submitted That Met QC Criteria

June 24, 2016

First Posted (Estimated)

June 28, 2016

Study Record Updates

Last Update Posted (Estimated)

September 11, 2025

Last Update Submitted That Met QC Criteria

September 5, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 69HCL16_0152

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Distress Syndrome

Clinical Trials on head-bed position

Subscribe